Effect of interferon alpha on HLA-DR expression by human buccal epithelial cells. 1996

J K Smith, and D S Chi, and G Krishnaswamy, and S Srikanth, and S Reynolds, and S L Berk
Department of Internal Medicine, East Tennessee State University, Johnson City 37614-0622, USA.

/We have studied the effect of interferon alpha (IFN-alpha) on MHC class II expression by human buccal epithelial cells (BEC), and mRNA expression by BEC and mucosal-associated mononuclear cells (MAMC). In 6 experiments, freshly collected BEC were suspended at a concentration of 1.0 x 10(5)/ml in RPMI 1640 and incubated in the presence of 0-10,000 IU/ml of human lymphoblastoid IFN-alpha (HuIFN-alpha). Zero and six hour samples were analyzed by single color flow cytometry using FITC-labeled murine IgG1 monoclonal antibody to HLA-DR. Preparations were also analyzed for expression of cytokine transcripts (IL-2, IL-4, IL-5, IL-6, IL-8, IFN-gamma, GM-CSF) by reverse transcriptase polymerase chain reaction (RT-PCR). Increasing concentrations of IFN-alpha resulted in proportionate increases in the percentage of HLA-DR + BEC (r = 0.7897, p = 0.0627) and in the percentage of HLA-DR+ staining at higher intensities (10(1) to 10(2) log fluorescence intensity) (LFI) (r = 0.4010, p = 0.0424). The percentage of HLA-DR + BEC rose from a mean of 1.5% with no IFN-alpha to 7% with 10,000 IU/ml IFN-alpha (p < 0.05). The percentage of HLA-DR + BEC staining at 10(1) to 10(2) LFI rose from a mean of 8.3% with no added IFN-alpha to 19.2% with 10,000 IU/ml IFN-alpha (p < 0.05). Unstimulated BEC constitutively expressed IL-8 and GM-CSF. IFN-alpha stimulated preparations also expressed IFN-gamma, possibly due to the presence of MAMC, which comprised 2-9% of the total cell population. These data indicated that HuIFN-alpha upregulates MHC class II expression by human BEC, possibly by enhancing IFN-gamma production by MAMC present in the culture preparations.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D009061 Mouth Mucosa Lining of the ORAL CAVITY, including mucosa on the GUMS; the PALATE; the LIP; the CHEEK; floor of the mouth; and other structures. The mucosa is generally a nonkeratinized stratified squamous EPITHELIUM covering muscle, bone, or glands but can show varying degree of keratinization at specific locations. Buccal Mucosa,Oral Mucosa,Mucosa, Mouth,Mucosa, Oral
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002610 Cheek The part of the face that is below the eye and to the side of the nose and mouth. Bucca,Buccas,Cheeks
D004848 Epithelium The layers of EPITHELIAL CELLS which cover the inner and outer surfaces of the cutaneous, mucus, and serous tissues and glands of the body. Mesothelium,Epithelial Tissue,Mesothelial Tissue,Epithelial Tissues,Mesothelial Tissues,Tissue, Epithelial,Tissue, Mesothelial,Tissues, Epithelial,Tissues, Mesothelial
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J K Smith, and D S Chi, and G Krishnaswamy, and S Srikanth, and S Reynolds, and S L Berk
December 1994, Investigative ophthalmology & visual science,
J K Smith, and D S Chi, and G Krishnaswamy, and S Srikanth, and S Reynolds, and S L Berk
October 1986, The American journal of pathology,
J K Smith, and D S Chi, and G Krishnaswamy, and S Srikanth, and S Reynolds, and S L Berk
September 1990, Pigment cell research,
J K Smith, and D S Chi, and G Krishnaswamy, and S Srikanth, and S Reynolds, and S L Berk
June 1986, Endocrinology,
J K Smith, and D S Chi, and G Krishnaswamy, and S Srikanth, and S Reynolds, and S L Berk
January 1991, Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie,
J K Smith, and D S Chi, and G Krishnaswamy, and S Srikanth, and S Reynolds, and S L Berk
November 1990, American journal of respiratory cell and molecular biology,
J K Smith, and D S Chi, and G Krishnaswamy, and S Srikanth, and S Reynolds, and S L Berk
May 1988, The Journal of clinical endocrinology and metabolism,
J K Smith, and D S Chi, and G Krishnaswamy, and S Srikanth, and S Reynolds, and S L Berk
July 1989, Experimental cell research,
J K Smith, and D S Chi, and G Krishnaswamy, and S Srikanth, and S Reynolds, and S L Berk
October 1994, Scandinavian journal of gastroenterology,
J K Smith, and D S Chi, and G Krishnaswamy, and S Srikanth, and S Reynolds, and S L Berk
August 1989, The British journal of ophthalmology,
Copied contents to your clipboard!